Lu, 2010 - Google Patents
Synthesis and properties of amino-and guanidino-peptoid peptide nucleic acidsLu, 2010
View PDF- Document ID
- 12588009781927019037
- Author
- Lu X
- Publication year
External Links
Snippet
Peptide nucleic acid (PNA) is a synthetic mimic of DNA and RNA that can bind to complementary DNA and RNA with high affinity and sequence specificity. The structural simplicity, high hybridization affinity and in vivo stability of PNA have made it an attractive …
- 230000015572 biosynthetic process 0 title abstract description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/314—Phosphoramidates
- C12N2310/3145—Phosphoramidates with the nitrogen in 3' or 5'-position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
- A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU680253B2 (en) | Novel peptide nucleic acids | |
| US8859490B2 (en) | Peptide nucleic acid monomers and oligomers | |
| EP0773950B1 (en) | Linked peptide nucleic acids | |
| Porcheddu et al. | Peptide nucleic acids (PNAs), a chemical overview | |
| WO2002097134A2 (en) | Modified peptide nucleic acid | |
| PL184920B1 (en) | Novel analogues of oligonucleotides, method of obtaining them and their application as well as pharmaceutic composition | |
| US6686442B2 (en) | Conjugated peptide nucleic acids having enhanced cellular uptake | |
| KR20110010691A (en) | Peptide nucleic acid derivatives having excellent cell permeability and strong nucleic acid affinity | |
| WO2023026994A1 (en) | Human transferrin receptor binding peptide-drug conjugate | |
| NZ501289A (en) | Conjugated peptide nucleic acids having enhanced cellular uptake | |
| CA2281843A1 (en) | Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove | |
| KR20170002649A (en) | Peptide nucleic acid monomers and oligomers | |
| CN110248956B (en) | HIF-1 alpha antisense oligonucleotides | |
| US20130231480A1 (en) | Sequence specific double-stranded dna/rna binding compounds and uses thereof | |
| CA2664632A1 (en) | Means and methods of enhancing delivery to biological systems | |
| Lu | Synthesis and properties of amino-and guanidino-peptoid peptide nucleic acids | |
| AU6778801A (en) | Positively-charged peptide nucleic acid analogs with improved properties | |
| MXPA02009738A (en) | Polyamide nucleic acid derivatives, agents and methods for producing the same. | |
| JP2004514427A (en) | PNA analog | |
| DK2079757T3 (en) | Method for selectively placing active substances on and in metochondria and corresponding active substances | |
| KR102304280B1 (en) | Acetyl-CoA Carboxylase2 Antisense Oligonucleotides | |
| JP2021506313A (en) | Divalent nucleic acid ligand and its use | |
| US20230235328A1 (en) | Novel morpholino oligonucleotide derivatives | |
| WO2025038901A1 (en) | Cyclic peptides for delivering therapeutics | |
| Zhu | Synthesis of Ethyl N-[(2-Boc-Amino)-Ethyl] Glycinate and PNA Monomer Containing 5-Iodouracil |